The tri-nucleotide spacer sequence between estrogen response element half-sites is conserved and modulates ERalpha-mediated transcriptional responses.
The estrogen response element (ERE) consensus sequence is AGGTCAnnnTGACCT, where nnn is known as the tri-nucleotide spacer sequence. Studying 1017 high-confidence ERalpha-bound loci, we found that genomic EREs are enriched for spacers composed of C(A/T)G, suggesting that the spacer may influence receptor binding and transcriptional responses. We designed consensus EREs containing variable spacer sequences and compared ERalpha binding in gel shift assays and enhancer function in reporter assays. We found that ERalpha-ERE binding affinity is modulated by the tri-nucleotide spacer sequence and is favored by spacer sequences of CTG>GCC>TTT. Similarly, luciferase reporter assays indicated that the estrogen-stimulated transcriptional response is modulated by the spacer and parallels the gel shift data: CTG>GCC>TTT. Reporter assays demonstrated that the spacer sequence also modulates the sensitivity of EREs to repression engendered by the receptor antagonist hydroxytamoxifen. These experiments indicate that the sequence of the tri-nucleotide spacer is non-random at receptor-bound genomic loci, influences ERalpha-DNA-binding affinity, and modulates transactivation potential of the receptor-ligand-DNA complex. This work has implications for understanding which genomic EREs are targeted by ERalpha, should improve computational prediction of functional EREs within genomic sequences, and describes novel sequence determinants of the estrogen response.
Shu
Feng-Jue
FJ
Department of Gynecology and Obstetrics, Emory University School of Medicine, 1639 Pierce Drive, WMB 4217, Atlanta, GA 30322, USA.
Sidell
Neil
N
Yang
Danzhou
D
Kallen
Caleb B
CB
D002460:Cell Line; D045744:Cell Line, Tumor; D047628:Estrogen Receptor alpha / Q000037:antagonists & inhibitors / Q000235:genetics*; D004967:Estrogens / Q000235:genetics*; D056426:Genetic Loci; D006801:Humans; D011485:Protein Binding; D020218:Response Elements; D014158:Transcription, Genetic
D047628:Estrogen Receptor alpha; D004967:Estrogens
Endocrinology. 2003 Jun;144(6):2325-35
12746293
Mol Endocrinol. 2005 Apr;19(4):833-42
15695368
EMBO J. 2009 May 20;28(10):1418-28
19339991
Mol Endocrinol. 1996 Jun;10(6):694-704
8776729
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11651-6
16087863
Science. 1991 Nov 22;254(5035):1210-4
1957173
Curr Protoc Bioinformatics. 2008 Mar;Chapter 2:Unit 2.6
18428685
Genome Res. 2009 Jun;19(6):967-77
19246569
Mol Endocrinol. 2007 Nov;21(11):2651-62
17666587
Mol Endocrinol. 1999 Oct;13(10):1672-85
10517669
N Engl J Med. 2006 Jan 19;354(3):270-82
16421368
J Clin Oncol. 1992 Feb;10(2):304-10
1732430
Cell. 1993 Nov 5;75(3):567-78
8221895
Structure. 1993 Nov 15;1(3):187-204
16100953
J Biol Chem. 1998 Nov 6;273(45):29321-30
9792632
Mol Syst Biol. 2008;4:188
18414489
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19199-204
19052240
Breast Cancer Res Treat. 2004 May;85(2):151-9
15111773
Mol Cell Biol. 1992 May;12(5):2037-42
1569939
J Mol Endocrinol. 2008 Nov;41(5):263-75
18772268
J Natl Cancer Inst. 1991 Oct 16;83(20):1477-82
1920493
J Biol Chem. 2005 Jun 3;280(22):21491-7
15790569
Genes Dev. 2009 Jul 1;23(13):1522-33
19515975
J Biol Chem. 2001 Nov 30;276(48):45282-8
11574541
Cancer Res. 2008 May 1;68(9):3505-15
18451179
Mol Endocrinol. 2004 Aug;18(8):1859-75
15031323
J Steroid Biochem Mol Biol. 2008 May;110(1-2):104-15
18400491
Nat Genet. 2006 Nov;38(11):1289-97
17013392
PLoS One. 2008;3(10):e3523
18949048
Science. 2008 Jan 11;319(5860):202-6
18187655
Mol Endocrinol. 2001 Jul;15(7):1114-26
11435612
Science. 1997 Sep 5;277(5331):1508-10
9278514
Mol Endocrinol. 2004 Jun;18(6):1411-27
15001666
Nucleic Acids Res. 2001 Jul 15;29(14):2905-19
11452016
J Steroid Biochem Mol Biol. 1998 Oct;67(2):79-88
9877207
J Biol Chem. 2004 Feb 6;279(6):5025-34
14617632
Mol Endocrinol. 2008 Nov;22(11):2393-406
18818283
Mol Cell Biol. 2007 Jul;27(14):5090-104
17515612
Nucleic Acids Res. 1984 Nov 26;12(22):8611-26
6504705
J Mol Endocrinol. 2002 Aug;29(1):137-52
12200235
Endocr Relat Cancer. 2009 Jun;16(2):381-9
19369485
Endocrinology. 2004 May;145(5):2291-6
14726435
Genome Res. 2006 Aug;16(8):962-72
16809671
PLoS Genet. 2007 Jun;3(6):e87
17542648
Cell. 1998 Dec 23;95(7):927-37
9875847
Nucleic Acids Res. 2008 Jan;36(1):76-93
17986456
Nucleic Acids Res. 1988 Jan 25;16(2):647-63
3340549
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):4893-8
11320240
Trends Endocrinol Metab. 2004 Mar;15(2):73-8
15036253
Cancer Res. 2006 Jul 15;66(14):7334-40
16849584
Mol Endocrinol. 2005 Apr;19(4):843-54
15637147
Cell. 2005 Jul 15;122(1):33-43
16009131
Science. 2009 Jun 26;324(5935):1720-3
19443739
Mol Cell Biol. 1998 Apr;18(4):1927-34
9528764
Cold Spring Harb Symp Quant Biol. 1993;58:141-7
7956024
J Biol Chem. 1994 Jun 3;269(22):15912-7
8195246
Lancet. 1998 May 16;351(9114):1451-67
9605801
Clin Cancer Res. 2004 Apr 1;10(7):2336-43
15073109
J Biol Chem. 2007 Jun 15;282(24):17335-9
17463000
Endocr Rev. 2004 Feb;25(1):45-71
14769827
Mol Cell Endocrinol. 2001 Jul 5;181(1-2):151-63
11476949
Nucleic Acids Res. 2004 Dec 01;32(21):6212-7
15576347
Nucleic Acids Res. 2010 Apr;38(7):2355-68
20047966
Cell. 2000 Dec 8;103(6):843-52
11136970
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):4852-7
17360330
Mol Cell Biol. 2009 Jun;29(12):3413-23
19364822